StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.31+0.14 (+0.77%)

Close on Nov 18, 2026Market cap $980.14MP/E –Yield –

Seaport Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$23.89M+78.2%
Q2 FY2026Jun 30, 2026$24.62M+133.7%
Q1 FY2026Mar 31, 2026$21.43M–
Q3 FY2025Sep 30, 2025$20.45M–
Q2 FY2025Jun 30, 2025$13.41M–
Q1 FY2025Mar 31, 2025$10.53M–

More Seaport Therapeutics figures

See a number that looks wrong?